1976 ~ 1985 서울대 의과대학 졸업 1992 ~ 1994 서울대 대학원 의학과 석사 1994 ~ 1996 서울대 대학원 의학과 박사
경력
1994 ~ 1995 서울대학교병원 외과 전임의 1995 ~ 2014 상계백병원 전임강사, 조교수, 부교수, 교수 2014 ~ 2018 아주대병원 유방암센터장 2014 ~ 2019 아주대병원 유방외과장 2014 ~ 현재 아주대 의과대학 외과 교수 2015 ~ 현재 한국유방암학회 이사장 Fellow of the American College of Surgeons International Society of Surgery International Association of Endocrine Surgery International HepatoPancreatoBiliary Association New York Academy of Science
논문
Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer. J Breast Cancer 14(4): 276-282, 2011
Comparison of CVF (cyclophosphamide + vinorelbine + 5-fluorouracil) and CMF (cyclophosphamide + methotrexate +5-fluorouracil) adjuvant chemotherapy in early breast cancer. J Breast Cancer 14(3): 223-228, 2011
Comparison of doxorubicin plus docetaxel neoadjuvant chemotherapy with doxorubicin plus vinorelbine in primary breast cancer. J Breast Cancer 14(2): 129-134, 2011
The prevalence of ovarian cancer in Korean Women at high-risk for hereditary breast-ovarian cancer. J Breast Cancer 14(s):S24-30, 2011
The prevalence and assessment of ErbB2-positive breast cancer in Asia. Cancer 116:5348-57, 2010
Lymphovascular invasion and HER2/neu amplification as predictive factors for axillary lymph node metastasis in early breast cancer patients. J Breast Cancer 13:250-256, 2010 ISSN 1738-6756
Accelerated partial breast irradiation using multicatheter brachytherapy for selected early-stage breast cancer: local control and toxicity. Radiation Oncology 5:56, 2010
Genomic change of chromosome 8 predicts the response to taxane-based neoadjuvant chemotherapy in node-positive breast cancer. Oncol Reports 24:121-128, 2010